Alnylam Pharmaceuticals Stock Options Expiring on 21st of February
| ALNY Stock | USD 276.73 2.03 0.73% |
Alnylam Pharmaceuticals' latest option contracts expiring on February 21st 2025 are carrying combined implied volatility of 0.47 with a put-to-call open interest ratio of 0.95 over 31 outstanding agreements suggesting . The total put volume is at 201, with calls trading at the volume of 165. This yields a 1.22 put-to-call volume ratio.
Open Interest Against February 21st 2025 Option Contracts
Alnylam Pharmaceuticals option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Alnylam Pharmaceuticals' lending market. For example, when Alnylam Pharmaceuticals' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Alnylam Pharmaceuticals, he or she must hedge the risk by shorting Alnylam Pharmaceuticals stock over its option's life.
2025-02-21
The chart above shows Alnylam Pharmaceuticals' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Alnylam Pharmaceuticals' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Alnylam Pharmaceuticals' option, there is no secondary market available for investors to trade.
Alnylam Pharmaceuticals Maximum Pain Price Across 2025-02-21 Option Contracts
Max pain occurs when Alnylam Pharmaceuticals' market makers reach a net positive position across all Alnylam Pharmaceuticals' options at a strike price where option holders stand to lose the most money. By contrast, Alnylam Pharmaceuticals' option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Alnylam Pharmaceuticals In The Money Call Balance
When Alnylam Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Alnylam Pharmaceuticals stock is said to be in the money. When it comes to buying Alnylam Pharmaceuticals' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Alnylam Pharmaceuticals are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Alnylam Current Options Market Mood
Alnylam Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Alnylam Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Alnylam Pharmaceuticals' options investors are not very successful. Alnylam Pharmaceuticals' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Alnylam contract
Base on the Rule 16, the options market is currently suggesting that Alnylam Pharmaceuticals will have an average daily up or down price movement of about 0.0294% per day over the life of the 2025-02-21 option contract. With Alnylam Pharmaceuticals trading at USD 276.73, that is roughly USD 0.0813. If you think that the market is fully incorporating Alnylam Pharmaceuticals' daily price movement you should consider buying Alnylam Pharmaceuticals options at the current volatility level of 0.47%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Alnylam |
Alnylam Pharmaceuticals Option Chain
When Alnylam Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Alnylam Pharmaceuticals stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Alnylam Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on Alnylam. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Alnylam. It also shows strike prices and maturity days for a Alnylam Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | ALNY250221C00220000 | 2 | 220.0 | 55.5 - 60.4 | 30.8 | In |
Call | ALNY250221C00230000 | 3 | 230.0 | 45.7 - 50.5 | 22.0 | In |
Call | ALNY250221C00240000 | 10 | 240.0 | 37.4 - 41.0 | 36.0 | In |
Call | ALNY250221C00250000 | 648 | 250.0 | 28.4 - 31.0 | 35.5 | In |
Call | ALNY250221C00260000 | 299 | 260.0 | 20.3 - 23.0 | 26.01 | In |
Call | ALNY250221C00270000 | 112 | 270.0 | 13.5 - 16.1 | 13.95 | In |
Call | ALNY250221C00280000 | 388 | 280.0 | 8.3 - 9.9 | 9.4 | Out |
Call | ALNY250221C00290000 | 58 | 290.0 | 4.6 - 5.8 | 5.0 | Out |
Call | ALNY250221C00300000 | 17 | 300.0 | 2.45 - 3.6 | 3.7 | Out |
Call | ALNY250221C00310000 | 2 | 310.0 | 1.2 - 2.35 | 1.8 | Out |
Call | ALNY250221C00320000 | 0 | 320.0 | 0.3 - 2.25 | 0.3 | |
Call | ALNY250221C00330000 | 0 | 330.0 | 0.25 - 0.85 | 0.25 | |
Call | ALNY250221C00340000 | 0 | 340.0 | 0.05 - 2.35 | 0.05 | |
Call | ALNY250221C00350000 | 0 | 350.0 | 0.0 - 2.3 | 2.3 | |
Call | ALNY250221C00360000 | 0 | 360.0 | 0.0 - 2.25 | 2.25 | |
Put | ALNY250221P00195000 | 3 | 195.0 | 0.0 - 1.5 | 0.81 | Out |
Put | ALNY250221P00210000 | 1 | 210.0 | 0.0 - 2.1 | 1.1 | Out |
Put | ALNY250221P00230000 | 196 | 230.0 | 0.0 - 1.25 | 0.65 | Out |
Put | ALNY250221P00240000 | 287 | 240.0 | 0.95 - 2.15 | 1.6 | Out |
Put | ALNY250221P00250000 | 428 | 250.0 | 1.9 - 3.5 | 1.6 | Out |
Put | ALNY250221P00260000 | 519 | 260.0 | 3.5 - 5.4 | 3.6 | Out |
Put | ALNY250221P00270000 | 3 | 270.0 | 6.5 - 8.1 | 6.5 | Out |
Put | ALNY250221P00280000 | 20 | 280.0 | 10.9 - 12.6 | 7.3 | In |
Put | ALNY250221P00290000 | 1 | 290.0 | 16.2 - 19.4 | 17.4 | In |
Put | ALNY250221P00300000 | 0 | 300.0 | 23.8 - 27.2 | 23.8 | In |
Put | ALNY250221P00310000 | 0 | 310.0 | 31.5 - 36.4 | 31.5 | In |
Put | ALNY250221P00320000 | 0 | 320.0 | 41.0 - 46.0 | 41.0 | In |
Put | ALNY250221P00330000 | 0 | 330.0 | 50.7 - 55.5 | 50.7 | In |
Put | ALNY250221P00340000 | 0 | 340.0 | 60.7 - 65.5 | 60.7 | In |
Put | ALNY250221P00350000 | 0 | 350.0 | 70.7 - 75.5 | 70.7 | In |
Put | ALNY250221P00360000 | 0 | 360.0 | 80.7 - 85.5 | 80.7 | In |
Alnylam Total Stockholder Equity
Total Stockholder Equity |
|
Alnylam Pharmaceuticals Corporate Management
| Saraswathy Nochur | Equity Diversity | Profile | |
| Indrani JD | Executive Secretary | Profile | |
| Evan Lippman | Chief Officer | Profile | |
| JD Esq | Chief Secretary | Profile | |
| Piyush JD | Chief Officer | Profile | |
| Alfred Boyle | Chief Officer | Profile | |
| Timothy Maines | Chief Officer | Profile |
Additional Tools for Alnylam Stock Analysis
When running Alnylam Pharmaceuticals' price analysis, check to measure Alnylam Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alnylam Pharmaceuticals is operating at the current time. Most of Alnylam Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Alnylam Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alnylam Pharmaceuticals' price. Additionally, you may evaluate how the addition of Alnylam Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.